Start Using PMS Guidance Ahead Of June Regulation, Says UK MHRA

Priority Accorded To Incident Traceability And Patient Safety In UK Regulator’s Device Program

GUIDANCE CONCEPT
The MHRA is to issue new guidance on biosimilars • Source: Shutterstock

More from United Kingdom

More from Policy & Regulation